Format

Send to

Choose Destination
JAMA Intern Med. 2018 Apr 1;178(4):567-569. doi: 10.1001/jamainternmed.2017.8016.

Medicare Spending and Potential Savings on Brand-Name Drugs With Available Generic Substitutes Excluded by 2 Large Pharmacy Benefit Managers, 2012 Through 2015.

Author information

1
Collaboration for Research Integrity and Transparency, Yale University, New Haven, Connecticut.
2
Section of General Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
3
Robert Wood Johnson Foundation Clinical Scholars Program, Veterans Affairs Connecticut Healthcare System, New Haven.
PMID:
29340562
PMCID:
PMC5876838
[Available on 2019-01-16]
DOI:
10.1001/jamainternmed.2017.8016

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center